| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 622924 | Null | 0.0149636429145596 | -0.23681099 |
| NSC 626876 | 2-Cyclopenten-1-one, 5-[(dimethylamino)methyl]-2-[2-[4- (2-methylpropyl)phenyl]propyl]-, hydrochloride | 0.0149636429145596 | 0.31753945 |
| NSC 732980 | 9-Hydroxy-5(3-phenylpropyl)-5H-indeno[1,2-b]indol-10-one | 0.0166986251090031 | 0.085698655 |
| NSC 175490 | Iron, carbonyl(.eta.5-2,4-cyclopentadien-1-yl)(di-4-morpholinylcarbamodithioato-S,S')- | 0.0186186224062458 | 0.29008139 |
| NSC 179074 | Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- | 0.0186186224062458 | 0.25705558 |
| NSC 264880 | Dihydro-5-azacytidine | 0.0186186224062458 | -0.0096607013 |
| NSC 301477 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- | 0.0186186224062458 | 0.33632649 |
| NSC 328785 | ANTINEOPLASTIC-328785 | 0.0186186224062458 | 0.32048741 |
| NSC 359463 | Null | 0.0186186224062458 | 0.51010567 |
| NSC 408400 | Null | 0.0186186224062458 | 0.17581851 |